These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7651500)

  • 1. $1 billion R&D spender emerges.
    Ward M
    Nature; 1995 Aug; 376(6542):626. PubMed ID: 7651500
    [No Abstract]   [Full Text] [Related]  

  • 2. Will R&D make Merck hot again?
    Simons J
    Fortune; 2002 Jul; 146(1):89-90, 92, 94. PubMed ID: 12119729
    [No Abstract]   [Full Text] [Related]  

  • 3. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 4. Concerns raised over declining antiinfectives R&D.
    Fox JL
    Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does the public sector have an independent research role in the development of drugs?].
    Poulsen HE; Grønlykke TB
    Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
    Ozdemir V; Williams-Jones B
    Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech R&D still reeling.
    Lawrence S
    Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical manufacturers ... leaving tradition behind and forging new managed care alliances.
    Barnett AA
    State Health Care Am; 1995; ():41-6. PubMed ID: 10168072
    [No Abstract]   [Full Text] [Related]  

  • 9. Misleading congress about drug development: Reply.
    Dimasi JA; Hansen RW; Grabowski HG
    J Health Polit Policy Law; 2008 Apr; 33(2):319-24; discussion 325-7. PubMed ID: 18325904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The $10 billion pill.
    Simons J
    Fortune; 2003 Jan; 147(1):58-62, 66, 68. PubMed ID: 12602122
    [No Abstract]   [Full Text] [Related]  

  • 11. GSK slashes internal R&D.
    Moran N
    Nat Biotechnol; 2008 Aug; 26(8):840. PubMed ID: 18688215
    [No Abstract]   [Full Text] [Related]  

  • 12. Examining the link between price regulation and pharmaceutical R&D investment.
    Vernon JA
    Health Econ; 2005 Jan; 14(1):1-16. PubMed ID: 15386673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report raises questions about drug companies advertising budgets.
    AIDS Policy Law; 1999 Aug; 14(14):1, 6. PubMed ID: 11366996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in R&D openness to tackle disease in the developing world.
    Parks L
    Future Med Chem; 2012 Dec; 4(18):2237. PubMed ID: 23234547
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient heal thyself.
    Benson RS
    Drug Discov Today; 2005 Feb; 10(3):159-61. PubMed ID: 15708524
    [No Abstract]   [Full Text] [Related]  

  • 16. Pfizer-Pharmacia merger bodes ill for biotech?
    Fletcher L
    Nat Biotechnol; 2002 Sep; 20(9):857-8. PubMed ID: 12205489
    [No Abstract]   [Full Text] [Related]  

  • 17. Bigger isn't always better.
    Nature; 2002 Jul; 418(6896):353. PubMed ID: 12140518
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing partners.
    Nat Biotechnol; 2002 Sep; 20(9):855. PubMed ID: 12205487
    [No Abstract]   [Full Text] [Related]  

  • 19. Outsourcing drug work. Pharmaceuticals ship R&D and clinical trials to India.
    Sinha G
    Sci Am; 2004 Aug; 291(2):24-5. PubMed ID: 15298112
    [No Abstract]   [Full Text] [Related]  

  • 20. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.